3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
Magnetic Resonance Spectroscopy
84
Specimen Handling
83
Cyclophosphamide
75
pembrolizumab
64
Radiotherapy
54
Nivolumab
52
fludarabine
44
Cisplatin
40
Biopsy
40
Carboplatin
39
Standard of Care
38
Bevacizumab
32
Dexamethasone
31
Rituximab
29
Gemcitabine
29
venetoclax
27
Surveys and Questionnaires
27
Radiosurgery
27
Radiation
27
Temozolomide
26
Practice Guidelines as Topic
26
Paclitaxel
25
Doxorubicin
25
Blood Specimen Collection
25
Cytarabine
24
fludarabine phosphate
23
Interviews as Topic
22
atezolizumab
21
Injections
20
Capecitabine
20
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Roflumilast
×
30 days
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled